Showing results (241-250 of 617) with videos related to
Sort By:
Pageof 62
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantationB Y Wang, Cherry, N S El-Badri, et al.Vox Sanguinis|January 1, 1988
Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communicationR H Rousell, R A Good, B Pirofsky, et al.The Journal of Clinical Investigation|June 1, 1977
Modulatory effects on immunoglobulin synthesis and secretion by lymphocytes from immunodeficient patientsS A Schwartz, Y S Choi, L Shou, et al.International Immunology|January 1, 1992
Clonal elimination of self reactive V beta 6+ T cells induced by H-2 products expressed on thymic radio-resistant componentsH Arase, N Arase, K Ogasawara, et al.Journal of Leukocyte Biology|October 1, 1992
A synthetic peptide homologous to retroviral envelope protein down-regulates TNF-alpha and IFN-gamma mRNA expressionS Haraguchi, R A Good, G J Cianciolo, et al.Cancer|March 15, 1980
Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implicationsB Safai, V Miké, G Giraldo, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1977
Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes from normal donorsS A Schwartz, L Shou, R A Good, et al.Journal of Clinical Immunology|November 1, 1985
Two natural killer-cell subpopulations distinguished by heat sensitivityS Inoue, S Ikehara, T Nakamura, et al.Southern Medical Journal|November 11, 1991
Intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy recalcitrant to conventional therapyK Urval, R P Nelson, S R Cohen, et al.Cellular Immunology|July 1, 1989
Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cellsR E Longley, D Stewart, K G Roe, et al.Pageof 62